Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Gut

• Publication date

  1982-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/gut.23.4.270PMID 6804309PMCID PMC1419734
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurotransmitters and CNS disease. Introduction.

  1982cited by this paper
• The long-term course of non-A, non-B post-transfusion hepatitis.

  1980cited by this paper
• Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-1980.

  1980cited by this paper
• The dominant role of non-A, non-B in the pathogenesis of post-transfusion hepatitis: a clinical assessment.

  1980cited by this paper
• The dominant role of non-A, non-B in the pathogenesis of post-transfusion hepatitis: a clinical assessment.

  1980cited by this paper
• The chronic sequelae of non-A, non-B hepatitis.

  1979cited by this paper
• Detection of virus-associated antigen in serum and liver of patients with non-A non-B hepatitis.

  1979cited by this paper
• Transmissible agent in non-A, non-B hepatitis.

  1978cited by this paper
• Hepatitis "C" antigen in non-A, non-B post-transfusion hepatitis.

  1978cited by this paper
• Transmission of non-A, non-B hepatitis from man to chimpanzee.

  1978cited by this paper
• Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of gamma-globulin prophylaxis in its prevention.

  1977cited by this paper
• Transmission of non-A, non-B hepatitis.

  1977cited by this paper
• Acute and chronic hepatitis revisited. Review by an international group.

  1977cited by this paper
• Classification of Chronic Hepatitis.

  1976cited by this paper
• Post-transfusion chronic liver disease.

  1976cited by this paper
• Letter: Surface characteristics of Hodgkin's cells.

  1975cited by this paper
• Letter: Zinc deficiency in man.

  1974cited by this paper
• Letter: Hereditary nephritis with immunofluorescent mesangial deposits.

  1973cited by this paper
• The vocabulary of chronic hepatitis.

  1971cited by this paper
• Morphological criteria in viral hepatitis. Review by an international group.

  1971cited by this paper
• A classification of chronic hepatitis.

  1968cited by this paper
• VASCULAR COMPLICATIONS OF CIRVICAL RIB.

  1963cited by this paper

• Breakthroughs in hepatitis C research: from discovery to cure

  2022cites this paper
• Hepatitis C Virus

  2020cites this paper
• From B to Non-B to C: The Hepatitis C Virus in Historical Perspective

  2019cites this paper
• An Immunodominant Epitope of the Human Immunodeficiency Virus Envelope Glycoprotein gp 160 Recognized by Class 1 Major Histocompatibility Com plex Molecule-Restricted Murine Cytotoxic

  2017cites this paper
• Natural history of chronic hepatitis C

  2016cites this paper
• Rapid Communications \ } Antibodies to hepatitis B core antigen in blood donors screened for alanine aminotransferase level and hepatitis nonA , non-B in recipients

  2012cites this paper
• GASTRENTEROLOGIA TÉCNICA E CLÍNICA - ESTÁGIO NO SERVIÇO DE GASTRENTEROLOGIA DO CENTRO HOSPITALAR DO PORTO

  2012cites this paper
• Morbidity and Mortality of Portal Hypertension

  2012cites this paper
• Post-transfusional vs. sporadic non-A, non-B chronic hepatitis. A clinico-pathological and evolutive study.

  2008cites this paper
• Chronic non-A, non-B hepatitis developed after transfusions, illicit self-injections or sporadically. Outcome during long-term follow-up--a comparison.

  2008cites this paper
• Histological evolution of chronic hepatitis C. Factors related to progression.

  2008cites this paper
• [Transfusion hepatitis. Occurrence and comparison of risks of blood transfusion and surgery].

  2008cites this paper
• Long-term follow-up of chronic post-transfusion non-A, non-B hepatitis: clinical and histological outcome.

  2008cites this paper
• Posttransfusion non-A, non-B hepatitis. A prospective study.

  2008cites this paper
• Long-term follow-up of chronic hepatitis non-A, non-B--with special reference to hepatitis C.

  2008cites this paper
• Elastografia hepática transitória: um método não invasivo para avaliação da fibrose em doentes com hepatite C crónica

  2007cites this paper
• Liver Disease in Children: Neonatal hepatitis and congenital infections

  2007cites this paper
• Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon a

  2006cites this paper
• Evaluation and quantification of morphological characteristics associated to hepatitis C virus infection: comparative study with hepatitis B.

  2006cites this paper
• Epidemiology of chronic viral hepatitis in the mediterranean area: Present status and trends

  2005cites this paper
• Estimating the Prognosis of Hepatitis C Patients Infected by Transfusion in Canada between 1986 and 1990

  2004cites this paper
• Non-A, non-B hepatitis

  2004cites this paper
• Morbidity of Chronic Hepatitis C as Seen in a Tertiary Care Medical Center

  2004cites this paper
• Structuration des processus de décision : le cas de la transfusion sanguine française (1950-1985)

  2004cites this paper
• Comparative histology of acute hepatitis B and non-A, non-B in Leuven and Padova

  2004cites this paper
• Hepatitis B and hepatitis C.

  2002cites this paper
• Transfusion‐Associated Hepatitis in a Tertiary Referral Hospital in India

  1999cites this paper
• Increased frequency of the HLA‐DR15 (B1*15011) allele in German patients with self‐limited hepatitis C virus infection

  1999cites this paper
• Transfusion–Associated Hepatitis in a Tertiary Referral Hospital in India

  1999cites this paper
• Interferon-α Therapy in Sicilian and Sardinian Polytransfused Thalassaemic Patients with Chronic Hepatitis C

  1999cites this paper
• Long-term re-treatment with interferon and ribavirin combination therapy in patients with chronic hepatitis C who are non-responders to interferon alone: a preliminary study.

  1999cites this paper
• T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable region.

  1999cites this paper
• Chronic hepatitis C: new diagnostic tools and therapeutic strategies

  1999cites this paper
• Long‐term administration of interferon‐α in non‐responder patients with chronic hepatitis C: follow‐up of liver fibrosis over 5 years

  1999cites this paper
• Reduced plasma transforming growth factor-beta1 levels in patients with chronic hepatitis C after interferon-alpha therapy: association with regression of hepatic fibrosis.

  1999cites this paper
• Ten year follow-up of patients with chronic hepatitis C treated with interferon.

  1999cites this paper
• Influence of the transmission route and disease duration in the histopathology of chronic hepatitis C: a study of 101 patients

  1998cites this paper
• Epidemiological risk factors and clinico-pathological presentation in chronic hepatitis C.

  1998cites this paper
• Interferon alpha treatment of chronic hepatitis C in HIV-infected patients receiving zidovudine: efficacy, tolerance and response related factors.

  1998cites this paper
• Prognosis of chronic hepatitis c: Results of a large, prospective cohort study

  1998cites this paper
• Diagnostic challenges of hepatitis C virus infections.

  1998cites this paper
• Interferon treatment of HCV positive cirrhotic patients.

  1998cites this paper
• Chronic hepatitis C: the virus, its discovery and the natural history of the disease

  1998cites this paper
• [National study of screening practices for hepatitis C among hemodialysis patients. Hepatitis Group].

  1998cites this paper
• How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C?

  1998cites this paper
• Antibodies to the Hypervariable Region Humans: Preferential Help for Induction of Multiple Class II MHC Molecules in Mice and from Hepatitis C Virus Envelope Protein with T Cell Recognition of Hypervariable Region-1

  1998cites this paper
• Comparison among Different Types, Dosages and Duration of Interferon Therapy in Chronic Hepatitis C

  1998cites this paper
• Hepatitis C Virus Infection in the Elderly

  1997cites this paper
• Incidence of hepatocellular carcinoma after interferon therapy in patients with chronic hepatitis C.

  1997cites this paper
• Safety and potential usefulness of liver biopsy in HIV‐seropositive haemophiliacs employing a transjugular venous approach

  1997cites this paper
• Interferon treatment of cirrhotic patients with chronic hepatitis C

  1997cites this paper
• Hepatocyctic proliferation in chronic liver disease: A study of liver biopsies using immunohistochemical localization of proliferating cell nuclear antigen.

  1997cites this paper
• Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.

  1997cites this paper
• Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.

  1997cites this paper
• [Monitoring of treated or non-treated chronic viral hepatitis C. 2: Criteria of efficacy and monitoring of treatment with interferon-alpha].

  1997cites this paper
• Jaundice at onset signifies a good prognosis in anti‐D‐associated HCV infection

  1997cites this paper
• HEPATOCYTIC PROLIFERATION IN CHRONIC LIVER DISEASE: A STUDY OF LIVER BIOPSIES USING IMMUNOHISTOCHEMICAL LOCALIZATION OF PROLIFERATING CELL NUCLEAR ANTIGEN

  1997cites this paper
• Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines.

  1996cites this paper
• Chronic Hepatitis C

  1996cites this paper
• AETIOPATHOGENESIS OF HEPATOCELLULAR CARCINOMA

  1996cites this paper
• Characteristics of hepatitis C virus among intravenous drug users in Iceland.

  1996cites this paper
• Identification of a murine CD4+ T-lymphocyte response site in hepatitis C virus core protein.

  1996cites this paper
• Analysis of HLA alleles in Japanese patients with cirrhosis due to chronic hepatitis C

  1996cites this paper
• T‐ and B‐cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti‐ hepatitis C virus—positive blood donors without viremi

  1996cites this paper
• Patterns of progression

  1996cites this paper
• T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.

  1996cites this paper
• Long-term administration of natural interferon-alpha in patients with chronic hepatitis C: relationship to serum RNA concentration, HCV-RNA genotypes, histological changes and hepatitis C virus.

  1996cites this paper
• Interferon as treatment for acute hepatitis C. A meta-analysis.

  1996cites this paper
• Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study.

  1996cites this paper
• [Compared efficiency of three strategies of management of chronic hepatitis C. Effect on the risk of cirrhosis 8 years after diagnosis].

  1996cites this paper
• Long‐term administration of natural interferon‐α in patients with chronic hepatitis C: Relationship to serum RNA concentration, HCV‐RNA genotypes, histological changes and hepatitis C virus

  1996cites this paper
• [Clinical picture and evolution of hepatitis C].

  1996cites this paper
• Interferon as treatment for acute hepatitis C

  1996cites this paper
• Case report: development of hepatocellular carcinoma in a patient with chronic hepatitis C infection after a complete and sustained response to interferon-alpha.

  1996cites this paper
• Sustained remission and viraemia in chronic hepatitis C treated with recombinant alpha-interferon (rIFN-alpha).

  1995cites this paper
• Clinical evolution of HCV-related chronic hepatitis.

  1995cites this paper
• Interferon-α Treatment in Patients with Chronic Hepatitis C

  1995cites this paper
• Prevalence and clinical course of hepatitis B and hepatitis C liver disease in ciclosporin-treated renal allograft recipients.

  1995cites this paper
• Unbiased usage of T‐cell receptor β variable region genes in peripheral blood cells of hepatitis C patients: No correlation with superantigen effect

  1995cites this paper
• [Natural history of hepatitis C virus infection].

  1995cites this paper
• Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alpha.

  1995cites this paper
• Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection

  1995cites this paper
• Ribavirin as Therapy for Chronic Hepatitis C

  1995cites this paper
• Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection

  1995cites this paper
• High dose interferon alpha-2b therapy for chronic hepatitis C: an open label study of the response and predictors of response.

  1995cites this paper
• Characterization of hepatitis C virus isolates from chronically infected patients

  1995cites this paper
• Interferon alpha treatment of chronic hepatitis C in patients with evidence for co-existent autoimmune dysregulation.

  1995cites this paper
• A retrospective study of hepatitis C virus carriers in a local endemic town in Japan

  1995cites this paper
• Hepatitis C virus-specific B cell activation: IgG and IgM detection in acute and chronic hepatitis C.

  1995cites this paper
• Hepatitis C virus infection and chronic liver disease in Ethiopia where hepatitis B infection is hyperendemic.

  1995cites this paper
• Interferon therapy in chronic hepatitis C virus: Evidence of different outcome with respect to different viral strains

  1995cites this paper
• The prevalence of antibodies to hepatitis C virus at two haemodialysis units in South Africa.

  1995cites this paper
• [Treatment of chronic hepatitis C with lymphoblastic interferon. Long-term follow-up].

  1995cites this paper
• Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

  1995cites this paper
• VIRAL HEPATITIS: AN OVERVIEW

  1995cites this paper
• Re‐treatment of interferon‐resistant patients with chronic hepatitis C with interferon‐α

  1995cites this paper
• Procollagen-III peptide and chronic viral C hepatitis.

  1995cites this paper
• Effect and side‐effects of alpha interferon treatment in haemophilia patients with chronic hepatitis C

  1995cites this paper
• COMPOUND OPIOID/PARACETAMOL ANALGESICS: MISUSE AND DEPENDENCE

  1995cites this paper
• Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates: Results of the first multicentre Australian trial

  1995cites this paper